SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of AeroClean Technologies (Nasdaq – AERC)

BALA CYNWYD – October 4, 2022 /Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of AeroClean Technologies. (“AeroClean” or the “Company”) (Nasdaq – AERC) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company’s agreement to merge with Molekule, Inc. (“Molekule”). Under the terms of the Merger Agreement, AeroClean stockholders will own 50.5%, and Molekule stockholders will own 49.5%, of the outstanding common equity of the combined company on a pro forma basis upon consummation of the merger. AeroClean will change its name and ticker symbol to Molekule, Inc. (Nasdaq – MKUL) upon consummation of the merger.

The investigation concerns whether the AeroClean Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to shareholders in the combined company.

If you own shares of AeroClean stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.